Legislation Curbing Drug Prices Was Supposed To Be One Of Few Bipartisan Wins This Year. Yet It Still Didn’t Happen.

It’s a congressional letdown that highlights the difficulty of legislating in a divided Washington and in taking on the powerful pharmaceutical industry. In other pharmaceutical news: doctors' financial links to pharma, Medicaid approval for a sickle cell treatment, the Ebola vaccine, and electronic records.

from Kaiser Health News https://ift.tt/34TwHo5